Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of Type 2 diabetes
US7750020B2 · kind B2 · utility
1Cited by
17References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2005 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Jun 27, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of the formula (I), which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, Type 2 diabetes and obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.